Alfiia Imanaeva
Tatchempharmpreparaty, Russia
Biography
Alfiia Imanaeva is a MD, private cardiologist. Her PhD work was devoted to a preclinical development of the new method of treatment of rheumatoid arthritis–both systemic and topical. Since 2014 she is a QPPV in JSC “Tatchempharmpreparaty”-a Russian manufacturer and marketing authorization holder, based in Kazan city. The company produces over 120 generic medications along with some original formulations and a variety of surgical threads. She witnessed the formation of the pharmacovigilance system in EAEU, passed each and every stage of the process and assembled a devoted team to ensure effective pharmacovigilance functioning in the company. Alongside in 2020 she founded a successful company that offers a range of writing services in pharmacovigilance, clinical trials and registration in EAEU.
Abstract
Abstract : Novelties of pharmacovigilance legislation in Eurasian Economic Union